Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Ivermectin use tied to lower mortality in patients with COVID-19

Jan. 26, 2021

Merck & Co. discontinues development of V-590 and V-591 vaccine candidates

Jan. 26, 2021

COLCORONA trial shows colchicine reduces risk of COVID-19-related complications

Jan. 25, 2021

Zydus reports phase IIb data on desidustat in patients with COVID-19

Jan. 25, 2021

Elasmogen identifies novel anti-COVID-19 therapeutic candidates

Jan. 25, 2021

MediciNova initiates phase II trial of ibudilast in COVID-19 patients at risk of ARDS

Jan. 25, 2021

Phase III data show bamlanivimab reduces risk of symptomatic COVID-19 in nursing homes

Jan. 22, 2021

SC-75741 potently inhibits the replication of bandaviruses in vitro

Jan. 22, 2021

Addition of tocilizumab does not improve clinical outcome in severe or critical COVID-19

Jan. 22, 2021

First participants dosed in phase II study of MV-012-968

Jan. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...